Varespladib: targeting the inflammatory face of atherosclerosis.
Benoit J
BJ
Arsenault
S Matthijs
SM
Boekholdt
John J P
JJ
Kastelein
D000085:Acetates / Q000008:administration & dosage*; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007211:Indoles / Q000008:administration & dosage*; D007651:Keto Acids; D008297:Male; D054497:Phospholipases A2, Secretory / Q000037:antagonists & inhibitors*
D000085:Acetates; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D007651:Keto Acids; C545088:varespladib methyl; D054497:Phospholipases A2, Secretory